Search

Thomas Fleischer

Time Series Analysis of Neoadjuvant Chemotherapy and Bevacizumab-Treated Breast Carcinomas Reveals a Systemic Shift in Genomic Aberrations
Abstract LB-337: Systemic Shift in Genomic Aberrations in Breast Carcinomas during Neoadjuvant Chemotherapy in Combination with Bevacizumab

Published with Wowchemy — the free, open source website builder that empowers creators.